Severe pancytopenia associated with the use of intravesical thio-TEPA.
D000368:Aged; D000741:Anemia, Aplastic / Q000139:chemically induced*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D013739:Testosterone / Q000627:therapeutic use; D013852:Thiotepa / Q000009:adverse effects*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D013739:Testosterone; D013852:Thiotepa; D011241:Prednisone